CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 1 filers reported holding CATALYST BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,708 | +36.1% | 32,528 | 0.0% | 0.00% | – |
| Q2 2023 | $11,538 | +70.9% | 32,528 | 0.0% | 0.00% | – |
| Q1 2023 | $6,753 | -60.5% | 32,528 | 0.0% | 0.00% | – |
| Q4 2022 | $17,080 | +0.5% | 32,528 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -70.2% | 32,528 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | +159.1% | 32,528 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -26.7% | 32,528 | 0.0% | 0.00% | – |
| Q4 2021 | $30,000 | -77.6% | 32,528 | 0.0% | 0.00% | – |
| Q3 2021 | $134,000 | -5.0% | 32,528 | 0.0% | 0.00% | – |
| Q2 2021 | $141,000 | +1.4% | 32,528 | +18.5% | 0.00% | – |
| Q1 2021 | $139,000 | +0.7% | 27,443 | +23.0% | 0.00% | – |
| Q4 2020 | $138,000 | +42.3% | 22,320 | +2.6% | 0.00% | – |
| Q3 2020 | $97,000 | +47.0% | 21,747 | +93.6% | 0.00% | – |
| Q2 2020 | $66,000 | – | 11,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
| ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
| 22NW, LP | 735,841 | $4,319,000 | 2.34% |
| Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
| Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
| Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
| Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
| Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
| Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
| Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |